Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,654 public trials 851 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL

NCT04697160

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • MorphoSys Research Site Scottsdale, Arizona, United States
  • MorphoSys Research Site Clovis, California, United States
  • MorphoSys Research Site Los Angeles, California, United States
  • MorphoSys Research Site Orange, California, United States
View all 165 locations
View Trial Details
Completed

Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)

NCT02038933

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Winship Cancer Center Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 46 locations
View Trial Details
Completed

Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT03576443

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Aarhus University Hospital Aarhus C, Denmark
  • Odense University Hospital Odense, Denmark
  • Halmstad County Hospital Halmstad, Sweden
  • Linkoping University Hospital Linköping, Sweden
View Trial Details
Completed

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

NCT02808442

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Hôpital Robert-Debré Paris, France
View Trial Details
Completed

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

NCT01381692

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions